In this session, Dr Reshma Mahtani provides breast cancer updates from the past year’s major meetings in oncology.

In this session moderated by Dr Reshma Mahtani, the panel will consider the case of a woman presenting with HER2+ metastatic breast cancer, with consideration to sequencing of therapies based on clinical factors.

In this session, Dr Komal Jhaveri provides breast cancer updates from the past year’s major meetings in oncology.

In this session moderated by Dr Komal Jhaveri, the panel considers current and emergent strategies for the treatment of triple-negative breast cancers.

In this session, moderated by Dr Kristina Mirabeau Beale, the panel considers differences in outcomes in minority populations, current inequities in cancer care and challenges faced by underserved populations with breast cancer.

In this session moderated by Dr Reshma Mahtani, the panel will consider the use of adjuvant treatments in the setting of patients with early stage, hormone receptor positive HER2 negative breast cancer.

In this session moderated by Dr Jennifer Klemp, the panel considers risk assessment and treatment for patients presenting with breast cancer and high-risk clinical features.

In this session moderated by Dr Komal Jhaveri, the panel will consider the use of precision medical approaches in breast cancer using CDK 4/6, mTOR, and PIK3CA inhibitors, next-generation sequencing (NGS) and circulating tumor DNA (ctDNA).